Authors:
Kline, T
Fromhold, M
McKennon, TE
Cai, S
Treiberg, J
Ihle, N
Sherman, D
Schwan, W
Hickey, MJ
Warrener, P
Witte, PR
Brody, LL
Goltry, L
Barker, LM
Anderson, SU
Tanaka, SK
Shawar, RM
Nguyen, LY
Langhorne, M
Bigelow, A
Embuscado, L
Naeemi, E
Citation: T. Kline et al., Antimicrobial effects of novel siderophores linked to beta-lactam antibiotics, BIO MED CH, 8(1), 2000, pp. 73-93
Authors:
Shawar, RM
MacLeod, DL
Garber, RL
Burns, JL
Stapp, JR
Clausen, CR
Tanaka, SK
Citation: Rm. Shawar et al., Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis, ANTIM AG CH, 43(12), 1999, pp. 2877-2880
Authors:
Westbrock-Wadman, S
Sherman, DR
Hickey, MJ
Coulter, SN
Zhu, YQ
Warrener, P
Nguyen, LY
Shawar, RM
Folger, KR
Stover, CK
Citation: S. Westbrock-wadman et al., Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability, ANTIM AG CH, 43(12), 1999, pp. 2975-2983
Authors:
Burns, JL
Van Dalfsen, JM
Shawar, RM
Otto, KL
Garber, RL
Quan, JM
Montgomery, AB
Albers, GM
Ramsey, BW
Smith, AL
Citation: Jl. Burns et al., Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis, J INFEC DIS, 179(5), 1999, pp. 1190-1196